20 - 22 February, 2012, Guoman Charing Cross, London, UK
LAST PLACES AVAILABLE – REGISTER TODAY!
Download the Brochure
Click here to access Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Are you capitalizing on the benefits to quality and compliance that accrue from adopting robust quality systems? Adoption of the ICH Q10 model for a pharmaceutical quality system should facilitate innovation, continual improvement and strengthen the link between pharmaceutical development and manufacturing activities. Learn how QbD principles combined with PAT technologies will facilitate to implement a robust pharmaceutical quality system according to ICH Q10 in the development and in manufacturing and how it will enable you to gain the benefits of establishing and maintaining a state of control, continual improvement, enhancing regulatory compliance and meeting quality objectives. Your workshop leader, Founder of Industrial Lab Automation, Peter Boogaard, attended the ISPE International Society for Pharmaceutical Engineering, PDA FDA and EMA Pharmaceutical Quality conference and will be able to demonstrate several use cases.
Working closely with Peter, you will learn…
PAT will lead to more process knowledge. More knowledge results in better understanding, less product variations, higher quality prediction, more robust processes and because we have more knowledge , identifying products who will not make final investigation will be earlier in the life cycle. Major savings.
PAT will lead to faster release of batches, because no off-line (laboratory) testing will be needed. QbD scientific risk based approach will result in less testing, because we gain more knowledge in the different manufacturing stages. Batch release can change from days to hours.
Meet you workshop leader:
Peter Boogaard, founder of Industrial Lab Automation Consultancy, studied analytical chemistry in Delft (The Netherlands). Here he was introduced to computer software during his research on inductively couples plasma (ICP) technology, now a de-facto standard in many analytical analysis methods. Peter started his international professional career with Perkin-Elmer Corporation. Thanks to his first employer, who understood very early on, the importance of the end-user experience, he created many application programs to for fill the client needs. Peter has been able to adopt and expand this behaviour successfully with great companies including Applied Biosystems, Oracle, Informix, Symyx, Life Technology and LabVantage. Peter has published several white papers and contributes in industry advisory boards.
[ Register Now ]
Questions? Contact us on 0800 652 2363 or +44 (0) 20 7368 9300 or email firstname.lastname@example.org now!